Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Leyi Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5311-2741; OpenAlex author ID A5101746626. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis. Co-author DOI 10.1111/jcmm.71230↗
  2. N4-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-025-03362-2↗
  3. Nudt21-mediated alternative polyadenylation of MZT1 3'UTR contributes to pancreatic cancer progression. Co-author DOI 10.1016/j.isci.2024.108822↗
  4. Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-023-02539-w↗
  5. Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response. Co-author DOI 10.3390/cancers15051442↗
  6. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and A… Co-author DOI 10.1038/s41419-021-03574-2↗
  7. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. Co-author DOI 10.1186/s12943-020-01196-4↗
  8. Tumor-neuroglia interaction promotes pancreatic cancer metastasis. Co-author DOI 10.7150/thno.42440↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Quanbo Zhou · 7 shared papers, 2020–2026 · strength 1.35
  2. Rufu Chen · 4 shared papers, 2020–2025 · strength 0.69
  3. Rihua He · 2 shared papers, 2025–2026 · strength 0.53
  4. Zhiqiang Fu · 3 shared papers, 2020–2025 · strength 0.48
  5. Yu Zhou · 2 shared papers, 2024–2025 · strength 0.48
  6. Jiabin Yang · 2 shared papers, 2023–2024 · strength 0.43
  7. Dan Su · 1 shared paper, 2026 · strength 0.29
  8. Xiaofeng Guo · 1 shared paper, 2026 · strength 0.29
  9. Rufu Chen · 1 shared paper, 2024 · strength 0.24
  10. Bin Zhang · 1 shared paper, 2024 · strength 0.22
  11. Liangtang Zeng · 1 shared paper, 2023 · strength 0.19
  12. Zhuo Kui Wu · 1 shared paper, 2023 · strength 0.19
  13. Min Yu · 1 shared paper, 2023 · strength 0.19
  14. Yu Zhou · 1 shared paper, 2023 · strength 0.19
  15. Lusheng Wei · 1 shared paper, 2021 · strength 0.14
  16. Yanan Lu · 1 shared paper, 2021 · strength 0.14
  17. Guolin Li · 1 shared paper, 2021 · strength 0.14
  18. Zhiguo Li · 1 shared paper, 2020 · strength 0.12
  19. Huilin Ye · 1 shared paper, 2020 · strength 0.12
  20. Dan Su · 1 shared paper, 2020 · strength 0.12
  21. Rufu Chen · 1 shared paper, 2020 · strength 0.10
  22. Xiaofeng Guo · 1 shared paper, 2020 · strength 0.10
  23. Zhiguo Li · 1 shared paper, 2020 · strength 0.10
  24. Changhao Chen · 1 shared paper, 2020 · strength 0.10
  25. Zhihua Li · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.